b.value

b.value AG operates as an early-stage venture capital firm, specializing in DeepTech investments. The firm identifies and funds startups leveraging disruptive technologies, primarily within biotechnology and advanced materials sectors. Their strategic focus encompasses pre-seed and seed stage companies located across the European D-A-CH region, aiming to support ventures that combine strong leadership with innovative solutions for a sustainable world.

Founded in 2016, b.value AG was established by Managing Directors Dipl.-Kfm. Peter Kallien and Dr. Georg Lentzen. Their collective insight stems from extensive entrepreneurial experience, including over two decades each in leading roles within science, biotech, and life science industries. This deep operational and industry knowledge underpins their approach to identifying and nurturing emerging DeepTech companies with significant potential.

The firm’s portfolio companies are pioneering enterprises in biotechnology and advanced materials, developing solutions for future markets. b.value AG’s vision is to cultivate a robust portfolio of fast-growing DeepTech startups that will define tomorrow's production processes and industries. They are committed to unlocking the full potential of core technologies to foster a sustainable future.